Gastric cancers with microsatellite instability exhibit high fluorodeoxyglucose uptake on positron emission tomography
Background Gastric cancers exhibit various degrees of 18 F-fluorodeoxyglucose (FDG) uptakes on positron emission tomography/computed tomography (PET/CT) imaging. The aim of this study was to evaluate whether FDG uptake in gastric cancer varies according to the microsatellite instability (MSI) status...
Saved in:
Published in | Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association Vol. 16; no. 2; pp. 185 - 192 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
Springer Japan
01.04.2013
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Gastric cancers exhibit various degrees of
18
F-fluorodeoxyglucose (FDG) uptakes on positron emission tomography/computed tomography (PET/CT) imaging. The aim of this study was to evaluate whether FDG uptake in gastric cancer varies according to the microsatellite instability (MSI) status.
Methods
Consecutive gastric cancer patients who underwent PET/CT imaging and MSI analysis were included in the study. The maximum standardized uptake value (SUV
max
) of gastric cancer was assessed using PET/CT imaging.
Results
Of 131 gastric cancers, 16 exhibited a high incidence of MSI (MSI-H) and 3 exhibited a low incidence of MSI (MSI-L). In 29 subjects who showed no uptake on PET/CT imaging the gastric cancers were all microsatellite stable (MSS). Gastric cancers with MSI were related to age older than 60 years (
p
= 0.002), cancer volume larger than 10 cm
3
(
p
= 0.015), and the presence of FDG uptake on PET/CT imaging (
p
= 0.001). A higher SUV
max
of gastric cancer was linked to the presence of MSI (
p
< 0.001).
Conclusion
The presence of MSI is related to FDG uptake in gastric cancer. Care should be taken with MSS gastric cancers, because they show lower SUV
max
on PET/CT imaging than MSI gastric cancers. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1436-3291 1436-3305 1436-3305 |
DOI: | 10.1007/s10120-012-0165-2 |